Medplus Subsidiary Faces One Day Suspension of Drug License in Karnataka
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Limited, has received an order suspending its Drug License for one day for a store located in Karnataka. The suspension was issued by the Assistant Director of the Drugs Control Administration, Chikkamagalore Circle.The action pertains to a store situated at Mallandur Road in Chikkamagaluru, Karnataka. The directive regarding the license suspension was received on June 24, 2026.
The regulatory action was initiated under Rule 65 of the Drugs and Cosmetics Act, 1940 and related Rules, 1945. The details surrounding the suspension order have been summarized as follows:
| Authority | Action Taken | Date of Order Receipt | Alleged Violation Details | Financial Impact |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration Chikkamagalore Circle, Karnataka. | Suspension of Drug License for one day of a store in Chikkamagaluru. | 24.06.2026 | Violation of Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules, 1945. | Potential Revenue Loss of Rs 0.46 lacs. |
The one-day suspension relates to the store in Chikkamagaluru and is expected to result in a potential revenue loss amounting to Rs 0.46 lacs for Optival Health Solutions Private Limited.
MEDPLUS Stock Price Movement
Shares of Medplus Health Services Limited on Thursday slipped by 0.35% to settle at ₹835, following a period of volatility in trading. The stock was traded across an intraday range spanning from a low of ₹828.3 to a high of ₹856.6, with total volume reaching 202,137 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.